Skip to main content
Clinical Trials/NCT05826808
NCT05826808CompletedNot Applicable

The Different Diagnostic Values of Polysomnographies at Low and at Moderate Altitude - A Randomized Crossover Trial

Tsogyal Latshang1 site in 1 country44 target enrollmentStarted: June 30, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
44
Locations
1
Primary Endpoint
T90 (time spent in SpO2 below 90%)

Study Overview

Brief Summary

The purpose of this study is to investigate the effect of short-term descent in healthy residents at moderate altitude (>1000 m.a.s.l.).

Detailed Description

Polysomnographies will be done for each participant for 2 consecutive nights at the sleep laboratory in Chur (CH; 590 m.a.s.l.) as well as for 2 consecutive nights at the participants home elevations (CH; >1000 m.a.s.l.). Between the measurements at those two different altitudes there will be a two-week washout period at >1000 m.a.s.l.. The sequence of altitude exposure will be randomized.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Diagnostic
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Healthy (no current medical condition or intake of regular medication, except negligible medical issues or accidents not interfering with the current health status or physical performance.)
  • Living above 1000 m.a.s.l. since at least 1 year
  • No overnight stay at altitudes <1000 m.a.s.l. in the previous 4 weeks
  • 18-70 years old
  • Body mass index 18,5-30 kg/m2
  • informed consent

Exclusion Criteria

  • Active diseases or health related conditions that require treatment (sleep disorders (mainly sleep apnea), chronic rhinitis, cardiovascular and lung diseases)
  • Use of drugs that affect the respiratory center drive (sedatives, sleep inducing drugs, opioids), stimulants or illegal drugs
  • Regular consumption of recreational drugs (alcohol and nicotine included)

Arms & Interventions

A

Experimental

Polysomnographies will be done first for 2 nights at the sleep laboratory in Chur (590 m.a.s.l.) and after a two-week washout period for 2 nights at the participants home elevations (>1000 m.a.s.l.).

Intervention: Descent to low altitude (Diagnostic Test)

B

Experimental

Polysomnographies will be done first for 2 nights at the participants home elevations (>1000 m.a.s.l.). and after a two-week washout period for 2 nights at sleep laboratory in Chur (590 m.a.s.l.).

Intervention: Descent to low altitude (Diagnostic Test)

Outcomes

Primary Outcomes

T90 (time spent in SpO2 below 90%)

Time Frame: 4 nights

T90 is the percent of sleeping time which the participant spent in SpO2 below 90%. It provides information about the duration and degree of hypoxia during the whole sleep.

Secondary Outcomes

  • SWS (slow-wave sleep)(4 nights)
  • AI (arousal index)(4 nights)
  • TcCO2 (partial pressure of carbon dioxide)(4 nights)
  • WASO (wakefulness after sleep onset)(4 nights)
  • ODI (oxygen desaturation index)(4 nights)
  • SpO2 (oxygen saturation)(4 nights)
  • AHI (apnea-hypopnea index)(4 nights)

Investigators

Sponsor
Tsogyal Latshang
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Tsogyal Latshang

Head of Pneumology

Kantonsspital Graubünden

Study Sites (1)

Loading locations...

Similar Trials

Effect of Short-term Descent to Low... | Clinical Trial